Equity Mates Investing Podcast

Replace your salary with dividend income

Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?

Moderna's recent mRNA-based cancer vaccine announcement, developed with Merck, highlights the transformative potential of biotechnology in oncology. While the news triggered a significant short-term surge in Moderna's stock price, it serves as a reminder of the volatility inherent in pharmaceutical development and the ...

Not all income is created equal with Helen Mason | Schroders

Data centre resistance grows, CSL is (sort of) back & a stock picker joins Pimp my Portfolio

How your financial plan changes as life changes with Matt Ingram

Banks flag a housing slowdown, AI won’t pick your stocks & Ren’s portfolio reviewed

4 investors, $100,000: Who’s winning 6 months in? | Portfolio Challenge

3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry

AI investors are getting nervous. Should they be?

We're back: AI selloff reverses, US earnings, Aussie property & more

The economics of the AI companies is being tested with Alex Pollak | Loftus Peak

Luxury: How Experiences Became the New Luxury | The Decade Ahead

Agriculture: Robots, Drones and the Future of Food | The Decade Ahead

Cybersecurity: The AI too dangerous to release to the public | The Decade Ahead

Emerging Middle Class: 300,000 New Consumers Every Day | The Decade Ahead

AI & Robotics: From $300bn to $5.2 trillion in three years | The Decade Ahead

Entertainment: The Smartphone Is Eating Hollywood | The Decade Ahead

Electrification: Australia’s Chance to Power the World | The Decade Ahead

Pet Care: Australia Has More Pets Than People | The Decade Ahead

Longevity: Can We Add Another 30 Years? | The Decade Ahead